EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

PREVALENCE, ANTIMICROBIAL SUSCEPTIBILITY PATTERN, AND EPIDEMIOLOGY OF EXTENDED-SPECTRUM BETA-LACTAMASES (ESBL) PRODUCING BACTERIA IN URINARY TRACT INFECTIONS IN A BRAZILIAN TERTIARY CARE HOSPITAL

Aline Dias Paiva, Julia Camargo Kabariti, Beatriz Aparecida Ferreira, Isabela Sguilla Rotta, Fernanda Machado Fonseca, Rodrigo Juliano Molina

REMUNOM · 05.03.2026 · 13 (01) · 1-18

DOI: 10.66104/52x15240 ↗

Kurz gefasst

Fachartikel in der Zeitschrift REMUNOM, online erschienen am 05.03.2026. Verfasst von Aline Dias Paiva und 5 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The prevalence of urinary tract infections (UTIs) caused by extended-spectrum beta-lactamase (ESBL)-producing Escherichia coli and Klebsiella pneumoniae is increasing worldwide. A retrospective analysis of medical records was conducted for patients with UTIs admitted to a general tertiary university hospital in Brazil, over a 1-year period (2022–2023). Among 1193 UTI episodes, 179 (15%) were caused by ESBL. No significant difference in sex was observed among cases of ESBL-causing UTI, and the mean age of the patients was 55 years (range: 1–102 years). Most ESBL-producing bacteria (70%) were isolated from hospitalized patients, with an average length of hospitalization of 27.5 days. Escherichia coli and Klebsiella pneumoniae were the predominant ESBL-producing species. Over 99% of ESBL isolates demonstrated resistance to third- and fourth-generation cephalosporins and aztreonam, whereas sensitivity to amikacin and polymyxin B was observed among the majority of bacterial strains, with carbapenems being the most effective drugs. Understanding antimicrobial resistance patterns in ESBL-producing strains associated with UTIs is crucial for guiding empirical antimicrobial therapy. Prompt implementation of infection control measures and rational use of antibiotics are essential to prevent the development and dissemination of ESBL-producing bacteria.

Zitieren

APA

Paiva, A. D., Kabariti, J. C., Ferreira, B. A., Rotta, I. S., Fonseca, F. M., & Molina, R. J. (2026). PREVALENCE, ANTIMICROBIAL SUSCEPTIBILITY PATTERN, AND EPIDEMIOLOGY OF EXTENDED-SPECTRUM BETA-LACTAMASES (ESBL) PRODUCING BACTERIA IN URINARY TRACT INFECTIONS IN A BRAZILIAN TERTIARY CARE HOSPITAL. REMUNOM, 13(01), 1-18. https://doi.org/10.66104/52x15240

Vancouver

Paiva AD, Kabariti JC, Ferreira BA, Rotta IS, Fonseca FM, Molina RJ. PREVALENCE, ANTIMICROBIAL SUSCEPTIBILITY PATTERN, AND EPIDEMIOLOGY OF EXTENDED-SPECTRUM BETA-LACTAMASES (ESBL) PRODUCING BACTERIA IN URINARY TRACT INFECTIONS IN A BRAZILIAN TERTIARY CARE HOSPITAL. REMUNOM. 2026;13(01):1-18. doi:10.66104/52x15240

BibTeX
@article{Paiva2026,
  author = {Paiva, Aline Dias and Kabariti, Julia Camargo and Ferreira, Beatriz Aparecida and Rotta, Isabela Sguilla and Fonseca, Fernanda Machado and Molina, Rodrigo Juliano},
  title = {PREVALENCE, ANTIMICROBIAL SUSCEPTIBILITY PATTERN, AND EPIDEMIOLOGY OF EXTENDED-SPECTRUM BETA-LACTAMASES (ESBL) PRODUCING BACTERIA IN URINARY TRACT INFECTIONS IN A BRAZILIAN TERTIARY CARE HOSPITAL},
  journal = {REMUNOM},
  year = {2026},
  volume = {13},
  number = {01},
  pages = {1--18},
  doi = {10.66104/52x15240}
}
Kostenlos starten →